Vidya, a globally recognised manufacturer of premium, sustainable probiotics, herbal extracts and innovative services, is proud to announce the launch of Biotical GH, the first ingredient to undergo a placebo-controlled study targeting the hair microbiome.
Biotical GH synergistically combines Vi-Spo, Vidya’s clinically studied saw palmetto extract, with a trio of spore-based probiotics.
This innovative formulation taps into the emerging science of the gut-hair axis, a powerful new pathway linking microbiome balance and follicular function.
The result is a two-pronged approach (probiotics and botanicals) that supports not only a visible increase in hair density, but also internal microbial balance essential to long-term scalp health.
“We are proud to be the first and only company to have conducted a placebo-controlled clinical trial focused specifically on the hair microbiome as an ingestible,” said Aleksander Richards, Director of Clinical R&D at Vidya.
In the clinical study, Biotical GH delivered impressive results — including a 30% increase in hair density and a 25% increase in follicular unit count after 24 weeks.
Even more compelling, the product demonstrated beneficial shifts in the scalp microbiome, fostering a healthier environment for long-term follicular resilience.
“It’s not just about adding good bacteria, it’s about fostering a dynamic, adaptable ecosystem that resists pathogen overgrowth and helps maintain scalp homeostasis,” Richards added.
“This study showed that Biotical GH does just that.”
Biotical GH represents a new approach in hair supplementation — making it a genuine beauty-from-within ingredient. By targeting hair microbiome balance through the gut-hair axis, this next-generation formula delivers visible, measurable results.
Biotical GH is now available for brand formulation and partnership opportunities.